Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00127231 · ClinicalTrials.gov registry record · NA

Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
148
Enrollment target

NCT00127231: Completed NA study, sponsored by Johns Hopkins University.

NCT00127231 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 148 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00127231, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
148 participants
Enrollment target

Study Summary

The purpose of this study is to determine whether two brief counseling sessions reduce drinking and improve health outcomes in HIV-positive women who drink at heavy/hazardous levels. Also, the study seeks to compare hazardous drinking versus nonhazardous drinking women on a variety of alcohol, HIV and life quality outcome measures.

Interventions

  • BEHAVIORAL Standard care
  • BEHAVIORAL Brief alcohol intervention based on Project Treat

Trial Details

FieldValue
Enrollment Target 148 participants
Start Date 2007-09
Est. Completion 2010-11
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT00127231 record still lists

NCT00127231 is an interventional study that assigns participants to a tested intervention. The registered 148 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard care is the first listed.

NCT00127231 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00127231 about?

NCT00127231 is a clinical study titled "Brief Therapy Intervention for Heavy/Hazardous Drinking in HIV-Positive Women". The purpose of this study is to determine whether two brief counseling sessions reduce drinking and improve health outcomes in HIV-positive women who drink at heavy/hazardous levels. Also, the study seeks to compare hazardous drinking versus nonhazardous drinking women on a variety of alcohol, HIV a...

What is the current status of trial NCT00127231?

This trial is currently completed. It is a NA study. The enrollment target is 148 participants. The study started on 2007-09. Estimated completion is 2010-11.

What interventions are being tested in trial NCT00127231?

The interventions under investigation include: Standard care (BEHAVIORAL), Brief alcohol intervention based on Project Treat (BEHAVIORAL).

Who is sponsoring clinical trial NCT00127231?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00127231's enrollment target sits among peer trials

148 702nd of 2000 higher than 1,298 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00739362 · 148 participants · Phase 2

    Effects of Brain Stimulation on Food Intake and Behavioral Weight Loss Treatment

  • NCT03161223 · 148 participants · Phase 1

    Durvalumab in Different Combinations With Pralatrexate, Romidepsin and Oral 5-Azacitidine for Lymphoma

  • NCT03858231 · 148 participants · Phase 4

    Opioids Versus Non-Opioids Postoperative After Knee Arthroscopic Surgery

  • NCT04486352 · 148 participants · Phase 1

    A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00127231, the US trial registry maintained by the National Library of Medicine. NCT00127231 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.